✦ LIBER ✦

Late Toxicity Is Not Increased in BRCA1/BRCA2 Mutation Carriers Undergoing Breast Radiotherapy in the United Kingdom

✍ Scribed by Buchholz, T.

Book ID: 123244177
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 63 KB
Volume: 18
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(07)80353-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute Chemotherapy–Related Toxicity Is N

Acute Chemotherapy–Related Toxicity Is Not Increased in BRCA1 and BRCA2 Mutation Carriers Treated for Breast Cancer in the United Kingdom

✍ Robson, M.E. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Oral contraceptive use increased the ris

Oral contraceptive use increased the risk of breast cancer in BRCA1, but not BRCA2, mutation carriers

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB

In carriers of BRCA1 and BRCA2 mutations

In carriers of BRCA1 and BRCA2 mutations, parity increased the risk of early breast cancer

✍ Nadine Andrieu 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Phenocopy breast cancer rates in Israeli

Phenocopy breast cancer rates in IsraeliBRCA1BRCA2mutation carrier families: is the risk increased in non-carriers?

✍ Shiri Bernholtz; Yael Laitman; Bella Kaufman; Shnai Shimon-Paluch; Eitan Friedma 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 192 KB

The rs2910164:G>C SNP in the MIR146A gen

The rs2910164:G>C SNP in the MIR146A gene is not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

✍ Amandine I. Garcia; David G. Cox; Laure Barjhoux; Carole Verny-Pierre; Daniel Ba 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

P7 The CHEK2 1100delC mutation is not pr

P7 The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation

✍ D.H. Choi; H.Y. Cho; M.H. Lee; H.S. Park; S.H. Ahn; B.G. Haffty 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 48 KB